Do it right. Do it better.

Beating cancer isn't easy. Neither is running a clinical trial. We need to do it right and do it better. 

At the Dana-Farber/Harvard Cancer Center, our investigators are renowned for cutting-edge and ground-breaking science. The ODQ brings that same innovative spirit to clinical research quality and operations. 

Let's move research forward. The fight against cancer is too important not to.

ODQ News & Updates

  • January 10, 2020 – PRMS

    Please review the following tips and tricks that the iRIS team has gathered to help you to interact with the system better.

  • January 10, 2020 – PRMS

    The application for Secondary Use, Medical Record Review, and Non-Human Subject Research Determination have been simplified to include only the regulatory questions needed for such submissions and no longer require a...

  • January 10, 2020 – PRMS

    A new operational form, Sponsor- Investigator Add External Site Form, has been added to the General Forms section of the study management page. This form is to be utilized for Investigator-Sponsored, Multi-Center...

Most Accessed Documents

  • Link
  • Link
  • Link
  • Link
  • Link